192 related articles for article (PubMed ID: 15981921)
1. Antitumor activity of beta-cyclodextrin polymer-camptothecin conjugates.
Cheng J; Khin KT; Davis ME
Mol Pharm; 2004; 1(3):183-93. PubMed ID: 15981921
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and biodistribution of the camptothecin-polymer conjugate IT-101 in rats and tumor-bearing mice.
Schluep T; Cheng J; Khin KT; Davis ME
Cancer Chemother Pharmacol; 2006 May; 57(5):654-62. PubMed ID: 16133526
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of linear, beta-cyclodextrin-based polymers and their camptothecin conjugates.
Cheng J; Khin KT; Jensen GS; Liu A; Davis ME
Bioconjug Chem; 2003; 14(5):1007-17. PubMed ID: 13129405
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vivo antitumor efficacy of PEGylated poly(l-lysine) dendrimer-camptothecin conjugates.
Fox ME; Guillaudeu S; Fréchet JM; Jerger K; Macaraeg N; Szoka FC
Mol Pharm; 2009; 6(5):1562-72. PubMed ID: 19588994
[TBL] [Abstract][Full Text] [Related]
5. MEN4901/T-0128, a new camptothecin derivative-carboxymethyldextran conjugate, has potent antitumor activities in a panel of human tumor xenografts in nude mice.
Fujita F; Koike M; Fujita M; Sakamoto Y; Okuno S; Kawaguchi T; Yano S; Yano T; Kiuchi S; Fujiwara T; Kudoh S; Kakushima M
Clin Cancer Res; 2005 Feb; 11(4):1650-7. PubMed ID: 15746070
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vivo antitumor activity of poly(l-glutamic acid) conjugates of 20S-camptothecin.
Bhatt R; de Vries P; Tulinsky J; Bellamy G; Baker B; Singer JW; Klein P
J Med Chem; 2003 Jan; 46(1):190-3. PubMed ID: 12502373
[TBL] [Abstract][Full Text] [Related]
7. Water-soluble poly-(L-glutamic acid)-Gly-camptothecin conjugates enhance camptothecin stability and efficacy in vivo.
Singer JW; Bhatt R; Tulinsky J; Buhler KR; Heasley E; Klein P; de Vries P
J Control Release; 2001 Jul; 74(1-3):243-7. PubMed ID: 11489501
[TBL] [Abstract][Full Text] [Related]
8. Biofunctionalized polymer-lipid supported mesoporous silica nanoparticles for release of chemotherapeutics in multidrug resistant cancer cells.
Zhang X; Li F; Guo S; Chen X; Wang X; Li J; Gan Y
Biomaterials; 2014 Apr; 35(11):3650-65. PubMed ID: 24462359
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth in vivo.
Yu D; Peng P; Dharap SS; Wang Y; Mehlig M; Chandna P; Zhao H; Filpula D; Yang K; Borowski V; Borchard G; Zhang Z; Minko T
J Control Release; 2005 Dec; 110(1):90-102. PubMed ID: 16271793
[TBL] [Abstract][Full Text] [Related]
10. Synergistic antitumor efficacy of hybrid micelles with mitochondrial targeting and stimuli-responsive drug release behavior.
Chen Z; Zhang Z; Chen M; Xie S; Wang T; Li X
J Mater Chem B; 2019 Mar; 7(9):1415-1426. PubMed ID: 32255012
[TBL] [Abstract][Full Text] [Related]
11. Nanosponge-encapsulated camptothecin exerts anti-tumor activity in human prostate cancer cells.
Minelli R; Cavalli R; Ellis L; Pettazzoni P; Trotta F; Ciamporcero E; Barrera G; Fantozzi R; Dianzani C; Pili R
Eur J Pharm Sci; 2012 Nov; 47(4):686-94. PubMed ID: 22917641
[TBL] [Abstract][Full Text] [Related]
12. Single-antibody, targeted nanoparticle delivery of camptothecin.
Han H; Davis ME
Mol Pharm; 2013 Jul; 10(7):2558-67. PubMed ID: 23676007
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effect of DX-8951, a novel camptothecin analog, on human pancreatic tumor cells and their CPT-11-resistant variants cultured in vitro and xenografted into nude mice.
Takiguchi S; Kumazawa E; Shimazoe T; Tohgo A; Kono A
Jpn J Cancer Res; 1997 Aug; 88(8):760-9. PubMed ID: 9330608
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of IHL-305, a novel pegylated liposome containing irinotecan, in human xenograft models.
Matsuzaki T; Takagi A; Furuta T; Ueno S; Kurita A; Nohara G; Kodaira H; Sawada S; Hashimoto S
Oncol Rep; 2012 Jan; 27(1):189-97. PubMed ID: 21935577
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and antitumor efficacy of XMT-1001, a novel, polymeric topoisomerase I inhibitor, in mice bearing HT-29 human colon carcinoma xenografts.
Walsh MD; Hanna SK; Sen J; Rawal S; Cabral CB; Yurkovetskiy AV; Fram RJ; Lowinger TB; Zamboni WC
Clin Cancer Res; 2012 May; 18(9):2591-602. PubMed ID: 22392910
[TBL] [Abstract][Full Text] [Related]
16. Injectable poly(organophosphazene)-camptothecin conjugate hydrogels: synthesis, characterization, and antitumor activities.
Cho JK; Chun C; Kuh HJ; Song SC
Eur J Pharm Biopharm; 2012 Aug; 81(3):582-90. PubMed ID: 22554767
[TBL] [Abstract][Full Text] [Related]
17. Preclinical study of the cyclodextrin-polymer conjugate of camptothecin CRLX101 for the treatment of gastric cancer.
Gaur S; Chen L; Yen T; Wang Y; Zhou B; Davis M; Yen Y
Nanomedicine; 2012 Jul; 8(5):721-30. PubMed ID: 22033079
[TBL] [Abstract][Full Text] [Related]
18. Polymeric tubulysin-peptide nanoparticles with potent antitumor activity.
Schluep T; Gunawan P; Ma L; Jensen GS; Duringer J; Hinton S; Richter W; Hwang J
Clin Cancer Res; 2009 Jan; 15(1):181-9. PubMed ID: 19118045
[TBL] [Abstract][Full Text] [Related]
19. Antitumor efficacy of colon-specific HPMA copolymer/9-aminocamptothecin conjugates in mice bearing human-colon carcinoma xenografts.
Gao SQ; Sun Y; Kopecková P; Peterson CM; Kopecek J
Macromol Biosci; 2009 Nov; 9(11):1135-42. PubMed ID: 19685500
[TBL] [Abstract][Full Text] [Related]
20. Preclinical results of camptothecin-polymer conjugate (IT-101) in multiple human lymphoma xenograft models.
Numbenjapon T; Wang J; Colcher D; Schluep T; Davis ME; Duringer J; Kretzner L; Yen Y; Forman SJ; Raubitschek A
Clin Cancer Res; 2009 Jul; 15(13):4365-73. PubMed ID: 19549776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]